GSK deal with McLaren brings racing technology to big pharma
GlaxoSmithKline (NYSE:GSK) wants to find out what auto racing can bring to pharmaceutical development. The London-based pharma giant is partnering with Formula 1 racing firm McLaren Group a deal that will apply McLaren’s engineering and technology to GSK’s global operations. The partnership will focus at first on GSK’s manufacturing, R&D and consumer healthcare operations. The […]